Senior insider sale
CMO & EVP Dev & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. — senior position signals high conviction
$2.88M
8.81K shares
What this filing means
GARG PUSHKAL plans to sell 8.81K shares of ALNYLAM PHARMACEUTICALS, INC. valued at approximately $2.88M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001969223-26-000295
Officer· CMO & EVP Dev & Med Affairs
Since Dec 2021
8.81K
Shares to sell
$2.88M
Approx. market value
2.40K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RSU
N/A
3/3/2026
2.40KTotal acquired2.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | RSU N/A | 2.40K | — |
| Total | 2.40K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.77K
Market value
$567.5K
3/3/2026
—Completed
Units to sell
4.63K
Market value
$1.53M
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.40K
Market value
$778.2K
3/5/2026
Total
Units
8.81K
Value
$2.88M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 1.77K | $567.5K | — | Completed |
2/27/2026 | 4.63K | $1.53M | — | Completed |
| Planned — Approximate Date | ||||
3/5/2026 | 2.40K | $778.2K | NASDAQ | Planned |
| Total | 8.81K | $2.88M | ||